Records containing: Kidney Transplant
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-07-11Randomized, Multi-Center Comparative Trial of Tacrolimus w/Steroids and Standard Daclizumab Induction vs a Novel Steroid-Free Tacrolimus Based Immunosuppression Protocol w/ Extended Daclizumab Induction in Pediatric Renal Transplantation
-
CLINICAL_TRIALS study record update · 2013-03-01Outcomes of Planned Conversion From Tacrolimus to Sirolimus-based Immunosuppressive Regimen in de Novo Kidney Transplant Recipients
-
CLINICAL_TRIALS study record update · 2013-02-20Pharmacogenetics of Mycophenolic Acid in Kidney Transplant Patients
-
CLINICAL_TRIALS study record update · 2013-02-08A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus Versus Cyclosporine When Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticosteroids in Primary De Novo Renal Allograft Recipients
-
CLINICAL_TRIALS study record update · 2013-01-03Long-term Kidney Function (2 Arms-Prospective and Retrospective)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-12-26Phase 1, Placebo-controlled, Randomized, Sequential, Parallel-group, Dose Escalation Study to Evaluate 28-day Multiple Dose Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CP-690,550 in Stable Renal Allograft Recipients
-
CLINICAL_TRIALS study record update · 2011-10-20A Prospective, Open-label, Controlled, Randomized Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After 90 to 150 Days After Kidney Transplantation in Adults, Maintaining Corticosteroid and Mycophenolate Sodium Compared to Patients Who Will Maintain the Use of Calcineurin Inhibitor
-
CLINICAL_TRIALS study record update · 2011-09-20Intensive Insulin Therapy in Deceased Donors - to Improve Renal Allograft Function and Transplanted Allograft Outcomes
-
CLINICAL_TRIALS study record update · 2011-09-14Humoral and Cell-mediated Immune Response to Influenza Vaccine in Kidney Tranpslant Recipients.
-
CLINICAL_TRIALS study record update · 2011-08-04Prospective Donor Specific Antibody (DSA) Monitoring Protocol To Detect Patient Characteristics and /or Changes In Immunosuppression on the Development of De Novo Antibodies
-
CLINICAL_TRIALS study record update · 2011-07-04Immunophenotyping and Functional Profiles of Peripheral Lymphocytes in Renal Transplant Recipients After T-cell Depletion With Alemtuzumab (Anti-CD52 Monoclonal Antibody)-Potential Implications for Safe Immunosuppressive Minimization
-
CLINICAL_TRIALS study record update · 2011-02-02A Nonrandomized, Open-label, Multicenter, Sequential Phase Study to Evaluate the Safety and Efficacy of Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese De Novo Renal Allograft Recipients Receiving Rapamune
-
CLINICAL_TRIALS study record update · 2010-12-22The Effects of Thymoglobulin on Antibody Screening Cells.
-
CLINICAL_TRIALS study record update · 2010-01-20A Randomized Open-label Study to Compare the Safety and Efficacy of Two Different Sirolimus Regimens With a Tacrolimus + Mycophenolate Mofetil Regimen in De Novo Renal Allograft Recipients.
-
CLINICAL_TRIALS study record update · 2009-06-30ClinicalTrials.gov study NCT00498576
-
CLINICAL_TRIALS study record update · 2008-05-15Patient Reported Outcomes in Renal Transplant Patients Tolerating GI Symptoms Converted to Myfortic (EC-MPS).
-
CLINICAL_TRIALS study record update · 2008-04-16Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy
-
CLINICAL_TRIALS study record update · 2008-03-25A Phase I/II Trial to Investigate the Safety and Efficacy of Rituximab and IVIG as Agents to Desensitize Highly-HLA Sensitized Dialysis Patients Awaiting Kidney Transplantation
-
CLINICAL_TRIALS study record update · 2008-01-03The Paired Donation Consortium Paired Donation Program
-
CLINICAL_TRIALS study record update · 2007-12-27A Randomized Open-Label Study to Compare the Safety and Efficacy of Two Different Sirolimus Regimens With a Tacrolimus + Mycophenolate Mofetil Regimen in De Novo Renal Allograft Recipients
-
CLINICAL_TRIALS study record update · 2007-07-03A Prospective, Longitudinal Study to Assess the Metabolic and Renal Effects of Rosiglitazone in Albuminuric Kidney Transplant Recipients
-
CLINICAL_TRIALS study record update · 2007-04-1212 Month, Prospective, Randomised, Open-Label Comparative Study to Evaluate the Protection of Kidney Function by Basiliximab in a CNI-Free Regimen in Newly Kidney Transplanted Patients (Three Months Post-Transplant) Who Are Recipient of One Kidney From Expanded Donor Criteria (UNOS Criteria)
-
CLINICAL_TRIALS study record update · 2006-05-22A Prospective, Randomized Study to Compare the Effect of Campath-1,Low Dose Sirolimus Versus Campath-1H, Low Dose CsA Both in Addition to Low Dose Mycophenolate Mofetil on Phenotypic and Functional Profiles of PBMCs in Kidney Transplant Recipients in a Steroid-Free Regimen